Arrakis Bio Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Arrakis Bio General Information
Description
Developer of RNA-targeted therapeutics designed for disease treatment purposes. The company utilizes proprietary discovery technologies and medicinal chemistry to identify, design, and optimize small-molecule drugs that bind to RNA, enabling the healthcare market to address previously undruggable targets and expand therapeutic options for a wide range of diseases by leveraging advanced RNA biology.
Contact Information
Website
www.arrakis.bioCorporate Office
- Tel Aviv
- Israel
Corporate Office
- Tel Aviv
- Israel
Arrakis Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 19-Jul-2023 | Completed | Startup |
Arrakis Bio Signals
Arrakis Bio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FLORA Ventures | Venture Capital | Minority |
Arrakis Bio FAQs
-
When was Arrakis Bio founded?
Arrakis Bio was founded in 2023.
-
Where is Arrakis Bio headquartered?
Arrakis Bio is headquartered in Tel Aviv, Israel.
-
What is the size of Arrakis Bio?
Arrakis Bio has 5 total employees.
-
What industry is Arrakis Bio in?
Arrakis Bio’s primary industry is Biotechnology.
-
Is Arrakis Bio a private or public company?
Arrakis Bio is a Private company.
-
What is Arrakis Bio’s current revenue?
The current revenue for Arrakis Bio is .
-
Who are Arrakis Bio’s investors?
FLORA Ventures has invested in Arrakis Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process